Related Experiment Videos
Our experience with EMLA Cream (for painless venous cannulation in children)
1Department of Anaesthesia, Postgraduate Institute of Medical Education and Research, Chandigarh.
Insights
EMLA Cream, a mixture of lidocaine and prilocaine, significantly reduced pain during venous cannulation in children. This topical anesthetic proved highly effective with minimal side effects, offering a better patient experience.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Pharmacology
Background:
- Venous cannulation is a common procedure in pediatric patients undergoing surgery.
- Pain and anxiety associated with venous cannulation can complicate procedures and affect patient recovery.
- Effective local analgesia is crucial for improving the pediatric patient experience during invasive procedures.
Purpose of the Study:
- To evaluate the local analgesic efficacy of EMLA Cream in reducing pain during venous cannulation in children.
- To compare the effectiveness of EMLA Cream against a placebo in a pediatric surgical population.
Main Methods:
- A randomized, blind study was conducted involving 75 children scheduled for elective surgery.
- EMLA Cream (lidocaine and prilocaine eutectic mixture) was applied to the venous cannulation site in 50 children one hour prior to the procedure.
- A placebo cream was applied to 25 children as a control group.
Main Results:
- EMLA Cream demonstrated high efficacy, with 84% of patients experiencing pain reduction compared to only 16% in the placebo group (P < 0.005).
- The local side effects associated with EMLA Cream application were found to be negligible.
- The study confirmed the significant analgesic effect of EMLA Cream for venous cannulation in pediatric patients.
Conclusions:
- EMLA Cream is a highly effective topical anesthetic for reducing pain associated with venous cannulation in children.
- The favorable efficacy and safety profile of EMLA Cream support its use in pediatric procedures requiring venous access.
- This study provides strong evidence for the routine use of EMLA Cream to improve procedural tolerance in pediatric patients.
Abstract:
The local analgesic efficacy of EMLA Cream (a eutectic mixture of lidocaine and prilocaine; Astra Pharmaceuticals, Sweden) in reducing the pain at Venous cannulation was investigated in a randommized blind study in 75 children scheduled for elective surgery. In 25 children placebo cream and in 50 children, EMLA cream was applied at the site of venous cannulation 1 hour prior. EMLA Cream was found to be highly effective (84% patients in contrast to 16% patients in placebo group; P less than 0.005). Local side effects of EMLA Cream were negligible.